- Home
- PRPO vs ADXN Comparison
PRPO vs ADXN Comparison
Compare PRPO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- ADXN
- Stock Information
- Founded
- PRPO N/A
- ADXN 2002
- Country
- PRPO United States
- ADXN Switzerland
- Employees
- PRPO N/A
- ADXN N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- ADXN Health Care
- Exchange
- PRPO Nasdaq
- ADXN Nasdaq
- Market Cap
- PRPO 9.5M
- ADXN 11.3M
- IPO Year
- PRPO N/A
- ADXN N/A
- Fundamental
- Price
- PRPO $6.25
- ADXN $7.80
- Analyst Decision
- PRPO
- ADXN Strong Buy
- Analyst Count
- PRPO 0
- ADXN 1
- Target Price
- PRPO N/A
- ADXN $30.00
- AVG Volume (30 Days)
- PRPO 7.5K
- ADXN 56.3K
- Earning Date
- PRPO 11-06-2024
- ADXN 11-22-2024
- Dividend Yield
- PRPO N/A
- ADXN N/A
- EPS Growth
- PRPO N/A
- ADXN N/A
- EPS
- PRPO N/A
- ADXN 0.05
- Revenue
- PRPO $17,411,000.00
- ADXN $960,641.00
- Revenue This Year
- PRPO $75.18
- ADXN N/A
- Revenue Next Year
- PRPO N/A
- ADXN N/A
- P/E Ratio
- PRPO N/A
- ADXN $1.44
- Revenue Growth
- PRPO 31.31
- ADXN N/A
- 52 Week Low
- PRPO $4.31
- ADXN $5.00
- 52 Week High
- PRPO $8.49
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- PRPO 52.41
- ADXN 31.62
- Support Level
- PRPO $6.14
- ADXN $7.86
- Resistance Level
- PRPO $6.47
- ADXN $9.89
- Average True Range (ATR)
- PRPO 0.19
- ADXN 0.93
- MACD
- PRPO 0.01
- ADXN -0.35
- Stochastic Oscillator
- PRPO 88.00
- ADXN 4.57
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.